Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (10539)	10/31/1997 8:01:00 PM
From: Andrew H	Read Replies (1) \| Respond to of 32384

Thanks, Henry. I have taken to printing out some of your more informative posts like this one. Hard for me to remember this stuff unless I review it, but it gets lost in the flurry of posts and becomes next to impossible to find. I count 8 here. What does LGND have in its pipeline now that belongs entirely to LGND? Its getting pretty hard to follow everything. Am I correct that all of these drugs you mention here will be developed and paid for by other companies? Also, I would imagine LGND is working on developing Targretin for emphysema. Have you heard anything about that? Will that belong entirely to LGND?